Takeda is one of just 17 companies that received global recognition, and it was additionally certified as a Top Employer across 24 countries. The Top Employers Institute program certifies organizations based on the participation and results of their HR Best…
Takeda and The New York Academy of Sciences today announced the winners of the 2024 Innovators in Science Award for their excellence in, and commitment to, innovative science that has significantly advanced the field of research in cancer immunology. Each…
Takeda announced that FDA has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate,…
Gamze Yüceland has been appointed as the President of Growth & Emerging Markets (GEM), Takeda. Having joined the Takeda family as the General Manager of Takeda Turkey eight years ago and later taking on significant roles in Canada and the…
The new partnerships bring its total contributions to JPY 24.2 billion (Approx. USD 167.5 million) across 29 long-term partnerships. Takeda’s workforce is an integral part of the annual decision-making process as over 24,500 purpose-led employees participated in the selection of…